Published in J Immunol on March 15, 1988
Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest (2000) 1.98
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol (1999) 1.39
Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24
Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol (1992) 1.22
Pathogenesis of onchocercal keratitis (River blindness). Clin Microbiol Rev (1999) 1.20
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol (1994) 1.19
HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci U S A (1994) 1.03
Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus. Infect Immun (2001) 1.01
Clinical and laboratory aspects of filariasis. Clin Microbiol Rev (1989) 0.98
Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda). J Exp Med (1995) 0.96
Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. J Clin Invest (1991) 0.95
Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis. Clin Exp Immunol (1991) 0.94
Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis. Infect Immun (1994) 0.92
In utero exposure to Onchocerca volvulus: relationship to subsequent infection intensity and cellular immune responsiveness. Infect Immun (1996) 0.92
Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls. Immunology (1999) 0.89
Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infection. PLoS Pathog (2013) 0.88
Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infect Immun (2002) 0.87
Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis. Infect Immun (2001) 0.81
Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms. PLoS One (2014) 0.80
The novel cuticular collagen Ovcol-1 of Onchocerca volvulus is preferentially recognized by immunoglobulin G3 from putatively immune individuals. Infect Immun (1997) 0.80
Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus. Clin Diagn Lab Immunol (1996) 0.80
Evaluation of the anti-inflammatory and anti-tumor effect of Ipomoea obscura (L) and its mode of action through the inhibition of proinflammatory cytokines, nitric oxide and COX-2. Inflammation (2011) 0.77
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
The ecology of trachoma: an epidemiological study in southern Mexico. Bull World Health Organ (1985) 3.91
Effect of ultraviolet radiation on cataract formation. N Engl J Med (1988) 3.59
Trachoma: evaluation of a new grading scheme in the United Republic of Tanzania. Bull World Health Organ (1987) 3.48
A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol (1992) 3.28
Age-standardization in epidemiological data. Int J Epidemiol (1994) 3.17
Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol (2003) 3.09
Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet (1995) 3.06
Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci (1991) 2.89
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69
Suppressor adherent cells in human tuberculosis. J Immunol (1978) 2.68
Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol (1996) 2.67
The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology (1998) 2.63
The environment and the lens. Br J Ophthalmol (1980) 2.59
The epidemiology of dry eye in Melbourne, Australia. Ophthalmology (1998) 2.58
Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol (1994) 2.52
Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci U S A (1990) 2.46
Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis (1993) 2.39
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Cataract: how much surgery do we have to do? Br J Ophthalmol (2000) 2.34
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS (2000) 2.32
Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol (1991) 2.29
Sequence organization of cloned intracisternal A particle genes. Cell (1980) 2.27
Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities. Br J Dermatol (2012) 2.23
Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol (1995) 2.21
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun (1988) 2.21
Diabetic retinopathy: examination practices and referral patterns of general practitioners. Med J Aust (1996) 2.19
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol (1989) 2.16
Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci U S A (1996) 2.15
Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis (1993) 2.14
Infective endocarditis caused by slow-growing, fastidious, Gram-negative bacteria. Medicine (Baltimore) (1979) 2.09
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis (1999) 2.06
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol (1986) 2.05
Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol (1996) 2.03
Prevalence and causes of vision loss in central Tanzania. Int Ophthalmol (1991) 2.02
The excimer laser in Australia. Med J Aust (1992) 2.01
The epidemiology of cataract in Australia. Am J Ophthalmol (1999) 2.01
Age-specific causes of bilateral visual impairment. Arch Ophthalmol (2000) 1.98
Vision impairment predicts 5 year mortality. Br J Ophthalmol (2001) 1.98
Prevalence and risk factors of myopia in Victoria, Australia. Arch Ophthalmol (1999) 1.95
Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.94
The epidemiology of trachoma in central Tanzania. Int J Epidemiol (1991) 1.93
Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology (2001) 1.90
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med (1986) 1.88
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol (1979) 1.87
An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science (1991) 1.86
Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model. Bull World Health Organ (1996) 1.83
Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol (2005) 1.82
Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother (1992) 1.82
Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77
The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis (1999) 1.76
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol (1995) 1.76
Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis (1994) 1.76
Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol (1996) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.74
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS (2001) 1.73
The prevalence of glaucoma among Eskimos of northwest Alaska. Arch Ophthalmol (1987) 1.72
Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol (2002) 1.72
Senile lens changes and diabetes in two population studies. Am J Ophthalmol (1981) 1.69
Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol (1994) 1.69
Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med (1999) 1.67
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol (2001) 1.67
The effect of prescription eyewear on ocular exposure to ultraviolet radiation. Am J Public Health (1986) 1.65
International ophthalmology strategic plan to preserve and restore vision-vision for the future. Am J Ophthalmol (2001) 1.65
A whole blood bactericidal assay for tuberculosis. J Infect Dis (2001) 1.65
The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64
The ocular dose of ultraviolet radiation from sunlight exposure. Photochem Photobiol (1985) 1.64
Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology (1993) 1.63
The effect of early cataracts on glare and contrast sensitivity. A pilot study. Arch Ophthalmol (1992) 1.61
Water availability and trachoma. Bull World Health Organ (1989) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J Clin Invest (1991) 1.60
Corneal changes associated with chronic UV irradiation. Arch Ophthalmol (1989) 1.59
Detection of hepatitis B virus DNA in tears by polymerase chain reaction. Arch Ophthalmol (1994) 1.57
Prevalence and predictors of undercorrected refractive errors in the Victorian population. Am J Ophthalmol (1999) 1.56
Prevalence of refractive error in rural Myanmar: the Meiktila Eye Study. Ophthalmology (2008) 1.54
Perforating ocular fishhook injury. Arch Ophthalmol (1992) 1.54
Schizophrenia, psychotropic medication, and cataract. Ophthalmology (1999) 1.54
In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci U S A (1997) 1.53
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis. Infect Immun (1995) 1.52
Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun (1989) 1.52
Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.51
Epidemiology of ocular trauma in Australia. Ophthalmology (1999) 1.50
Pseudoexfoliation syndrome in Australian adults. Am J Ophthalmol (2000) 1.48
Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest (1980) 1.48